Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001179022-18-000026)

Filing Details

Accession Number:
0001179022-18-000026
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-04-18 16:31:45
Reporting Period:
2018-04-16
Accepted Time:
2018-04-18 16:31:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1133416 Galectin Therapeutics Inc GALT Pharmaceutical Preparations (2834) 043562325
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1413699 Daniel Theodore Zucconi C/O Galectin Therapeutics, Inc.
4960 Peachtree Industrial Blvd., Ste 240
Norcross GA 30071		 Yes No No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-04-16 4,000 $0.89 5,083 No 4 M Direct
Common Stock Disposition 2018-04-16 4,000 $3.58 1,083 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Show Other Fields >>
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock option (right to buy) Disposition 2018-04-16 4,000 $0.00 4,000 $0.89
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
27,250 2026-12-15 No 4 M Direct
Footnotes
  1. The options vested 100% on the date of Galectin Therapeutics, Inc.'s 2017 Annual Stockholders Meeting.